{"product_id":"partruvix-ef-bc-88pamiparib-ef-bc-89","title":"PARTRUVIX（Pamiparib）","description":"\u003cp\u003ePamiparib  (BGB-290) is a drug used to treat various types of cancer. It's a PARP inhibitor, which means it prevents the repair of DNA breaks. \u003c\/p\u003e\u003cul\u003e\u003cli\u003e\n\u003cspan data-huuid=\"5813577302449632437\"\u003eSocazolimab \u003c\/span\u003esold under the brand name 百汇泽(PARTRUVIX)® in china.\u003c\/li\u003e\u003c\/ul\u003e\u003cp\u003e Based on the results from the pivotal phase II portion of a phase I\/II trial (NCT03333915) pamiparib was recently approved in China for the treatment of germline BRCA mutation-associated recurrent advanced ovarian, fallopian tube or primary peritoneal cancer previously treated with two or more lines of chemotherapy.\u003c\/p\u003e","brand":"BeiGene Biotechnology, China","offers":[{"title":"Default Title","offer_id":44797957013547,"sku":"RL3220250101","price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/2025-01-144.png?v=1787022275","url":"https:\/\/xomeds.com\/products\/partruvix-ef-bc-88pamiparib-ef-bc-89","provider":"XOMEDS","version":"1.0","type":"link"}